Brain Imaging in Alzheimer Disease

Johnson, K. A., Fox, N. C., Sperling, R. A., Klunk, W. E.·2012·Cold Spring Harbor Perspectives in Medicine
DOI 10.1101/cshperspect.a006213

Cites (238)

Items 201–238 of 238

  1. Women at risk for AD show increased parietal activation during a fluency task
    Charles D. Smith, Anders H. Andersen, Richard J. Kryscio, Frederick A. Schmitt, Mark S. Kindy, Lee Xenakis Blonder, Malcolm J. Avison · 2002 · Neurology
  2. High PIB Retention in Alzheimers Disease is an Early Event with Complex Relationship with CSF Biomarkers and Functional Parameters
    Anton Forsberg, Ove Almkvist, Henry Engler, A. Wall, Bengt Långström, Agneta K. Nordberg · 2010 · Current Alzheimer Research
  3. PET Amyloid Ligand [11C]PIB Uptake and Cerebrospinal Fluid β-Amyloid in Mild Cognitive Impairment
    Jaana Koivunen, Tuula Pirttilä, Nina M. Kemppainen, Sargo Aalto, Sanna‐Kaisa Herukka, A.M. Jauhianen, Tuomo Hänninen, Merja Hallikainen, Kjell Någren, Juha O. Rinne et al. · 2008 · Dementia and Geriatric Cognitive Disorders
  4. Preclinical Evidence of Alzheimer Changes
    Eric C. Petrie, Donna J. Cross, Douglas R Galasko, Gerard D. Schellenberg, Murray A. Raskind, Elaine R. Peskind, Satoshi Minoshima · 2009 · Archives of Neurology
  5. Multitracer PET imaging of amyloid plaques and neurofibrillary tangles in Alzheimer's disease
    Jonghan Shin, Sang‐Yoon Lee, So‐Hee Kim, Young-Bo Kim, Seong‐Jin Cho · 2008 · NeuroImage
  6. Correlating Cerebral Hypometabolism With Future Memory Decline in Subsequent Converters to Amnestic Pre–Mild Cognitive Impairment
    Richard J. Caselli, Kewei Chen, Wendy Lee, Gene E. Alexander, Eric M. Reiman · 2008 · Archives of Neurology
  7. Pharmacological Modulation of Behavioral and Neuronal Correlates of Repetition Priming
    Christiane M. Thiel, Richard N. Henson, John S. Morris, Karl John Friston, Raymond J. Dolan · 2001 · Journal of Neuroscience
  8. Multimodal imaging in mild cognitive impairment: Metabolism, morphometry and diffusion of the temporal–parietal memory network
    Kristine Beate Walhovd, Anders M. Fjell, Inge K. Amlien, Ramunė Grambaitė, Vidar Tveit Vasfaret Stenset, Atle Bjørnerud, Ivar Reinvang, Leif Gjerstad, Tone Cappelen, Paulina Due‐Tønnessen · 2008 · NeuroImage
  9. Impaired Medial Temporal Repetition Suppression is Related to Failure of Parietal Deactivation in Alzheimer Disease
    Maija M. Pihlajamaki, Kristina M. DePeau, Deborah Blacker, Reisa Anne Sperling · 2008 · American Journal of Geriatric Psychiatry
  10. Longitudinal Study of CSF Biomarkers in Patients with Alzheimer's Disease
    Peder Buchhave, Kaj Blennow, Henrik Zetterberg, Erik Stomrud, Elisabet Londos, Niels Andreasen, Lennart Minthon, Oskar Hansson · 2009 · PLoS ONE
  11. Prognostic Value of Posteromedial Cortex Deactivation in Mild Cognitive Impairment
    Jeffrey R. Petrella, Steven E. Prince, Lihong Wang, Caroline Hellegers, Pudugramam Murali Doraiswamy · 2007 · PLoS ONE
  12. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease
    William Edward Klunk, Chester A. Mathis, Julie C. Price, Brian J. Lopresti, Steven Trent DeKosky · 2006 · Brain
  13. Cholinergic Stimulation Enhances Neural Activity Associated with Encoding but Reduces Neural Activity Associated with Retrieval in Humans
    J. Kukolja, C. Thiel, G. Fink · 2009 · Journal of Neuroscience
  14. Evidence of Altered Posteromedial Cortical fMRI Activity in Subjects at Risk for Alzheimer Disease
    Maija M. Pihlajamaki, Kelly O’Keefe, Lars Bertram, Rudolph E. Tanzi, Bradford Clark Dickerson, Deborah Blacker, Marilyn Albert, Reisa Anne Sperling · 2010 · Alzheimer Disease & Associated Disorders
  15. Single domain amnestic MCI: A multiple cognitive domains fMRI investigation
    Andrea Lenzi, Laura Serra, Roberta Perri, Patrizià Pantano, G. L. Lenzi, Eraldo Paulesu, Carlo Caltagirone, Marco Bozzali, Emiliano Macaluso · 2009 · Neurobiology of Aging
  16. Mild cognitive impairment (MCI) and actual retrieval performance affect cerebral activation in the elderly
    Reinhard Heun, Katrin Freymann, Michael Erb, Dirk Leube, Frank Jessen, Tilo T. J. Kircher, Wolfgang Grodd · 2006 · Neurobiology of Aging
  17. Diagnosis and management of Alzheimer’s disease and other disorders associated with dementia. The role of neurologists in Europe
    Gunhild Waldemar · 2000 · European Journal of Neurology
  18. Higher serum total cholesterol levels in late middle age are associated with glucose hypometabolism in brain regions affected by Alzheimer's disease and normal aging
    Eric M. Reiman, Kewei Chen, Jessica B. S. Langbaum, Wendy Lee, Cole Reschke, Daniel J. Bandy, Gene E. Alexander, Richard J. Caselli · 2009 · NeuroImage
  19. Altered medial temporal lobe responses during visuospatial encoding in healthy APOE*4 carriers
    Paul R. Borghesani, L. Clark Johnson, Amy Lynne Shelton, Elaine R. Peskind, Elizabeth Aylward, Gerard D. Schellenberg, Monique M. Cherrier · 2007 · Neurobiology of Aging
  20. 11C-PiB PET studies in typical sporadic Creutzfeldt-Jakob disease
    Victor L. Villemagne, Catriona McLean, Katrina A. Reardon, A Boyd, Victoria Lewis, Genevieve M Klug, Gareth R. Jones, David Baxendale, Colin Louis Masters, Christopher Cleon Rowe et al. · 2009 · Journal of Neurology Neurosurgery & Psychiatry
  21. Test–retest reliability of fMRI verbal episodic memory paradigms in healthy older adults and in persons with mild cognitive impairment
    Francis Clément, Sylvie Belleville · 2009 · Human Brain Mapping
  22. Patterns of temporal lobe atrophy in semantic dementia and Alzheimer's disease
    Dennis Chan, Nick C. Fox, Rachael I. Scahill · 2001 · Annals of Neurology
  23. Molecular imaging in the diagnosis of Alzheimer's disease: visual assessment of [11C]PIB and [18F]FDDNP PET images
    Nelleke Tolboom, Wiesje M. van der Flier, Jolanda Boverhoff, Maqsood M. Yaqub, Mike Peter Wattjes, Pieter G.H.M. Raijmakers, Frederik Barkhof, Philip Scheltens, Karl Herholz, Adriaan A. Lammertsma et al. · 2010 · Journal of Neurology Neurosurgery & Psychiatry
  24. Regulation of Choline Acetyltransferase
    Paul M. Salvoterra, James E. Vaughn · 1989 · International review of neurobiology
  25. Aβ1–42 promotes cholinergic sprouting in patients with AD and Lewy body variant of AD
    Eliezer Masliah, Michael F. Alford, Anthony Adame, Edward M. Rockenstein, Douglas Galasko, David P. Salmon, Lawrence A. Hansen, Leon J. Thal · 2003 · Neurology
  26. Alzheimer disease identification using amyloid imaging and reserve variables
    Catherine M. Roe, Mark A. Mintun, Nupur Ghoshal, Monique Williams, E Grant, Daniel S. Marcus, John C. Morris · 2010 · Neurology
  27. Regional brain activity after prolonged cholinergic enhancement in early Alzheimer's disease
    Michael Fraser Shanks, William Jonathan McGeown, Katrina Forbes‐McKay, Gordon D. Waiter, Mario G. Ries, Annalena Venneri · 2007 · Magnetic Resonance Imaging
  28. Decreased Activation Along the Dorsal Visual Pathway After a 3-Month Treatment With Galantamine in Mild Alzheimer Disease
    Arun L.W. Bokde, Michaela Karmann, Stefan Johannes Teipel, Christine Born, Martin Lieb, Maximilian Ferdinand Reiser, Hans‐Jürgen Möller, Harald Juergen Hampel · 2009 · Journal of Clinical Psychopharmacology
  29. Mental calculation impairment in Alzheimer's disease: a functional magnetic resonance imaging study
    Florence Rémy, Fakhereh Mirrashed, Barry I. Campbell, Wolfgang Richter · 2004 · Neuroscience Letters
  30. Amyloid, hypometabolism, and cognition in Alzheimer disease: An [11C]PIB and [18F]FDG PET study
    A. Verma · 2008 · Yearbook of Neurology and Neurosurgery
  31. Cholesterol-related genetic risk scores are associated with hypometabolism in Alzheimer's-affected brain regions
    Eric M. Reiman, Kewei Chen, Richard J. Caselli, Gene E. Alexander, Daniel J. Bandy, Jennifer L. Adamson, Wendy Lee, Ashley D. Cannon, Elizabeth A. Stephan, Dietrich A. Stephan et al. · 2008 · NeuroImage
  32. Reliability of functional magnetic resonance imaging associative encoding memory paradigms in non‐demented elderly adults
    Deepti Putcha, Kelly O’Keefe, Pete S. LaViolette, Jackie O’Brien, Douglas N. Greve, Dorene M. Rentz, Joseph J. Locascio, Alireza Atri, Reisa Anne Sperling · 2011 · Human Brain Mapping
  33. Effects of Risk Genes on BOLD Activation in Presymptomatic Carriers of Familial Alzheimer's Disease Mutations during a Novelty Encoding Task
    John Matthew Ringman, Luis Daniel Medina, Meredith N. Braskie, Yaneth Rodríguez‐Agudelo, Daniel H. Geschwind, Miguel Ángel Macías-Islas, Jeffrey L. Cummings, Susan Y. Bookheimer · 2010 · Cerebral Cortex
  34. Parietal cortex activation predicts memory decline in apolipoprotein E-εε4 carriers
    Johanna Lind, Martin Ingvar, Jonas Persson, Kristel Sleegers, Christine Van Broeckhoven, Rolf Adolfsson, Lars‐Göran Nilsson, Lars H Nyberg · 2006 · Neuroreport
  35. Imaging of Amyloid Burden and Distribution in Cerebral Amyloid Angiopathy
    Ajay Kumar Verma · 2008 · Yearbook of Neurology and Neurosurgery
  36. Responders to ChEI Treatment of Alzheimers Disease Show Restitution of Normal Regional Cortical Activation
    Annalena Venneri, William Jonathan McGeown, Michael Fraser Shanks · 2009 · Current Alzheimer Research
  37. fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease
    Nikolaos Scarmeas, Yaakov Stern · 2005 · Neurology
  38. Untitled work
    1999 · 10.1002/1531-8249(199904)45:4